Child Maltreatment — New Parent Support Program Evaluation
Citation(s)
Curran GM, Bauer M, Mittman B, Pyne JM, Stetler C Effectiveness-implementation hybrid designs: combining elements of clinical effectiveness and implementation research to enhance public health impact. Med Care. 2012 Mar;50(3):217-26. doi: 10.1097/MLR.0b013e3182408812.
Howard KS, Brooks-Gunn J The role of home-visiting programs in preventing child abuse and neglect. Future Child. 2009 Fall;19(2):119-46. doi: 10.1353/foc.0.0032.
Kaminski JW, Valle LA, Filene JH, Boyle CL A meta-analytic review of components associated with parent training program effectiveness. J Abnorm Child Psychol. 2008 May;36(4):567-89. doi: 10.1007/s10802-007-9201-9. Epub 2008 Jan 19.
Kaye, M P., Faber, A., Schiavone, W., & Perkins, D. F. (2016). New Parent Support Program Engagement Phase II Final Report. University Park, PA: Clearinghouse for Military Family Readiness at Penn State.
Kaye, M P., Ferrara, A. M., Abram-Erby, G., Kotch, R., Gernon, S., & Perkins, D. F. (2021, April). Take Root Home Visitation implementation: Army New Parent Support Program (NPSP) EIII. University Park, PA: Clearinghouse for Military Family Readiness at Penn State.
Kelley, M L., Schwerin, M. J., Farrar, K. L., & Lane, M. E. (2006). A participant evaluation of the U.S. Navy parent support program. Journal of Family Violence, 21, 301-310. https://doi.org/10.1007/s10896-006-9031-5
Navy and Marine Corps New Parent Support Program Evaluation
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.
